Matthew Brams

1.3k total citations
40 papers, 995 citations indexed

About

Matthew Brams is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cognitive Neuroscience. According to data from OpenAlex, Matthew Brams has authored 40 papers receiving a total of 995 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Psychiatry and Mental health, 11 papers in Clinical Psychology and 11 papers in Cognitive Neuroscience. Recurrent topics in Matthew Brams's work include Attention Deficit Hyperactivity Disorder (35 papers), Bipolar Disorder and Treatment (18 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Matthew Brams is often cited by papers focused on Attention Deficit Hyperactivity Disorder (35 papers), Bipolar Disorder and Treatment (18 papers) and Child and Adolescent Psychosocial and Emotional Development (9 papers). Matthew Brams collaborates with scholars based in United States, Switzerland and Cayman Islands. Matthew Brams's co-authors include Ann Childress, Maria Gasior, Robert L. Findling, Joseph Gao, Rafael Muniz, Timothy Wigal, Frank A. López, Linda Pestreich, Alice R. Mao and Sharon B. Wigal and has published in prestigious journals such as PEDIATRICS, Journal of the American Academy of Child & Adolescent Psychiatry and Journal of Autism and Developmental Disorders.

In The Last Decade

Matthew Brams

40 papers receiving 903 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Brams United States 20 915 400 193 166 97 40 995
Thomas Spencer United States 9 775 0.8× 332 0.8× 257 1.3× 111 0.7× 154 1.6× 14 881
Brigette S. Vaughan United States 15 581 0.6× 234 0.6× 243 1.3× 135 0.8× 66 0.7× 28 662
Péter Nagy Hungary 14 379 0.4× 254 0.6× 180 0.9× 69 0.4× 35 0.4× 26 575
Thomas A. Rugino United States 12 464 0.5× 362 0.9× 84 0.4× 51 0.3× 81 0.8× 15 636
Breck Borcherding United States 7 461 0.5× 220 0.6× 133 0.7× 111 0.7× 90 0.9× 9 537
Samuel S. Kupietz United States 13 495 0.5× 242 0.6× 159 0.8× 217 1.3× 72 0.7× 22 655
Bryan Dirks United States 15 492 0.5× 211 0.5× 141 0.7× 43 0.3× 90 0.9× 37 601
Larry J. Klassen Canada 8 587 0.6× 267 0.7× 195 1.0× 60 0.4× 62 0.6× 13 783
Meghan Dougherty United States 8 501 0.5× 197 0.5× 115 0.6× 37 0.2× 57 0.6× 8 574
Tatiana Usala Italy 4 335 0.4× 168 0.4× 132 0.7× 59 0.4× 34 0.4× 7 432

Countries citing papers authored by Matthew Brams

Since Specialization
Citations

This map shows the geographic impact of Matthew Brams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Brams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Brams more than expected).

Fields of papers citing papers by Matthew Brams

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Brams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Brams. The network helps show where Matthew Brams may publish in the future.

Co-authorship network of co-authors of Matthew Brams

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Brams. A scholar is included among the top collaborators of Matthew Brams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Brams. Matthew Brams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cutler, Andrew J., Scott H. Kollins, Matthew Brams, et al.. (2024). Serdexmethylphenidate/dexmethylphenidate for children with attention-deficit/hyperactivity disorder: dose optimization from a laboratory classroom study. Frontiers in Psychiatry. 15. 1310483–1310483. 1 indexed citations
2.
Childress, Ann, et al.. (2023). Safety and Tolerability of Serdexmethylphenidate/Dexmethylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder: A 12-Month, Open-Label Safety Study. Journal of Child and Adolescent Psychopharmacology. 33(2). 51–58. 5 indexed citations
3.
Kollins, Scott H., Rene A. Braeckman, Andrew C. Barrett, et al.. (2021). A Randomized, Controlled Laboratory Classroom Study of Serdexmethylphenidate and d-Methylphenidate Capsules in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 31(9). 597–609. 27 indexed citations
4.
Brams, Matthew, et al.. (2021). Assessment of the Impact of Tardive Dyskinesia in Clinical Practice: Consensus Panel Recommendations. Neuropsychiatric Disease and Treatment. Volume 17. 1589–1597. 15 indexed citations
5.
Childress, Ann, et al.. (2020). Efficacy and Safety of Multilayer, Extended-Release Methylphenidate (PRC-063) in Children 6–12 Years of Age with Attention-Deficit/Hyperactivity Disorder: A Laboratory Classroom Study. Journal of Child and Adolescent Psychopharmacology. 30(10). 580–589. 14 indexed citations
6.
7.
Childress, Ann, et al.. (2017). Efficacy and Safety of Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 28(5). 306–313. 18 indexed citations
8.
Weiden, Peter J., Leslie Citrome, Gus Alva, et al.. (2014). A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia. Schizophrenia Research. 153(1-3). 160–168. 16 indexed citations
9.
Cutler, Andrew J., Matthew Brams, Oscar G. Bukstein, et al.. (2014). Response/Remission With Guanfacine Extended-Release and Psychostimulants in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 53(10). 1092–1101. 19 indexed citations
10.
Silva, Raul R., et al.. (2013). Extended-Release Dexmethylphenidate 30 mg/d Versus 20 mg/d. Clinical Neuropharmacology. 36(4). 117–121. 6 indexed citations
11.
Brams, Matthew, et al.. (2012). A Randomized, Double-Blind Study of 30 Versus 20 mg Dexmethylphenidate Extended-Release in Children With Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology. 32(5). 637–644. 11 indexed citations
12.
Mao, Alice R., Matthew Brams, T. Babcock, & Manisha Madhoo. (2011). A Physician's Guide to Helping Patients with ADHD Find Success in the Workplace. Postgraduate Medicine. 123(5). 60–70. 7 indexed citations
13.
Wigal, Sharon B., Tim Wigal, Sabrina Schuck, et al.. (2011). Academic, Behavioral, and Cognitive Effects of OROS ® Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 21(2). 121–131. 50 indexed citations
14.
Wilens, Timothy E., Oscar G. Bukstein, Matthew Brams, et al.. (2011). A Controlled Trial of Extended-Release Guanfacine and Psychostimulants for Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 51(1). 74–85.e2. 82 indexed citations
15.
Brams, Matthew, et al.. (2010). Duration of effect of oral long-acting stimulant medications for ADHD throughout the day. Current Medical Research and Opinion. 26(8). 1809–1825. 25 indexed citations
16.
17.
Brams, Matthew, Rafael Muniz, Ann Childress, et al.. (2008). A Randomized, Double-Blind, Crossover Study of Once-Daily Dexmethylphenidate in Children with Attention-Deficit Hyperactivity Disorder. CNS Drugs. 22(8). 693–704. 37 indexed citations
18.
Silva, Raul R., Rafael Muniz, Linda Pestreich, et al.. (2008). Dexmethylphenidate ExtendeD-Release Capsules in Children With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry. 47(2). 199–208. 24 indexed citations
19.
Silva, Raul R., Rafael Muniz, Linda Pestreich, et al.. (2006). Efficacy and Duration of Effect of Extended-Release Dexmethylphenidate Versus Placebo in Schoolchildren With Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. 16(3). 239–251. 39 indexed citations
20.
Silva, Raul, Rafael Muniz, Linda Pestreich, et al.. (2005). Efficacy of Two Long-Acting Methylphenidate Formulations in Children with Attention- Deficit/Hyperactivity Disorder in a Laboratory Classroom Setting. Journal of Child and Adolescent Psychopharmacology. 15(4). 637–654. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Spencer Breakdown of academic impact, for papers by Brigette S. Vaughan Breakdown of academic impact, for papers by Péter Nagy Breakdown of academic impact, for papers by Thomas A. Rugino Breakdown of academic impact, for papers by Breck Borcherding Breakdown of academic impact, for papers by Samuel S. Kupietz Breakdown of academic impact, for papers by Bryan Dirks Breakdown of academic impact, for papers by Larry J. Klassen Breakdown of academic impact, for papers by Meghan Dougherty Breakdown of academic impact, for papers by Tatiana Usala
Rankless by CCL
2026